Endo Pharmaceuticals has reached a $50 million settlement in the New York Opioid Jury Trial. “This result is a victory for everyone as it ensures resources will be delivered to communities in need without having to deal with the potential for bankruptcy proceedings,” Counsel for Nassau County said Partner Hunter Shkolnik. Download